Over the past 12 months, Relmada Therapeutics insiders bought $4.03 million of stock on the open market (1.44Mn shares) and made no open-market sales.
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Sergio Traversa | Chief Executive Officer | 1,500,000 | 0 | 1,500,000 | 43.9% | 11 Sep, 2026 |
| 2 | Maged Shenouda | Chief Financial Officer | 1,000,000 | 0 | 1,000,000 | 29.3% | 11 Sep, 2026 |
| 3 | Paul Edward Kelly | Chief Operating Officer | 502,295 | 0 | 502,295 | 14.7% | 06 Nov, 2025 |
| 4 | Chuck Ence | Cao And Coo | 403,931 | 0 | 403,931 | 11.8% | 06 Nov, 2025 |
| 5 | Cedric O'Gorman | Chief Medical Officer | 10,121 | 0 | 10,121 | 0.3% | 24 May, 2023 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 09 Sep, 2026 | Sergio Traversa | Chief Executive Officer | Acquired P | 100,000 | $4.18 | $418.00K | 1,400,000 | Direct |
| 09 Sep, 2026 | Maged Shenouda | Chief Financial Officer | Acquired P | 120,200 | $4.20 | $504.84K | 920,200 | Direct |
| 10 Sep, 2026 | Sergio Traversa | Chief Executive Officer | Acquired P | 100,000 | $4.10 | $410.00K | 1,500,000 | Direct |
| 10 Sep, 2026 | Maged Shenouda | Chief Financial Officer | Acquired P | 79,800 | $4.25 | $339.15K | 1,000,000 | Direct |
| 15 Dec, 2025 | Maged Shenouda | Chief Financial Officer | Acquired P | 11,665 | $4.12 | $48.06K | 800,000 | Direct |
| 12 Dec, 2025 | Charles J Casamento | Director | Acquired A | 164,000 | $0.00 | $0 | 164,000 | Direct |
| 15 Dec, 2025 | Sergio Traversa | Chief Executive Officer | Acquired P | 27,500 | $4.12 | $113.30K | 1,300,000 | Direct |
| 12 Dec, 2025 | Chuck Ence | Ca And Co | Acquired A | 828,000 | $0.00 | $0 | 828,000 | Direct |
| 12 Dec, 2025 | John Glasspool | Director | Acquired A | 164,000 | $0.00 | $0 | 164,000 | Direct |
| 12 Dec, 2025 | Fabiana Fedeli | Director | Acquired A | 164,000 | $0.00 | $0 | 164,000 | Direct |
| 12 Dec, 2025 | Paul Edward Kelly | Coo | Acquired A | 828,000 | $0.00 | $0 | 828,000 | Direct |
| 12 Dec, 2025 | Sergio Traversa | Chief Executive Officer | Acquired A | 1,198,000 | $0.00 | $0 | 1,198,000 | Direct |
| 12 Dec, 2025 | Maged Shenouda | Chief Financial Officer | Acquired A | 828,000 | $0.00 | $0 | 828,000 | Direct |
| 05 Nov, 2025 | Maged Shenouda | Chief Financial Officer | Acquired P | 500,000 | $2.20 | $1.10Mn | 788,335 | Direct |
| 05 Nov, 2025 | Paul Edward Kelly | Chief Operating Officer | Acquired P | 90,000 | $2.20 | $198.00K | 502,295 | Direct |
| 05 Nov, 2025 | Sergio Traversa | Chief Executive Officer | Acquired P | 272,500 | $2.20 | $599.50K | 1,272,500 | Direct |
| 05 Nov, 2025 | Chuck Ence | Cao And Coo | Acquired P | 136,000 | $2.20 | $299.20K | 403,931 | Direct |
| 26 Aug, 2025 | Sergio Traversa | Chief Executive Officer | Acquired P | 80,545 | $0.62 | $49.94K | 814,569 | Direct |
| 27 Aug, 2025 | Sergio Traversa | Chief Executive Officer | Acquired P | 129,455 | $0.67 | $86.73K | 944,024 | Direct |
| 28 Aug, 2025 | Sergio Traversa | Chief Executive Officer | Acquired P | 55,976 | $0.74 | $41.42K | 1,000,000 | Direct |